

Selecta Biosciences, a biopharmaceutical company, develops nanoparticle immunomodulatory drugs for the treatment and prevention of diseases. Among its major competitors, Selecta Biosciences is ranked in 6th place for NPS while Biogen is 1st, and Athersys is 2nd.Their current market cap is $207.89M